Concepedia

Aparna Padiyar

AP

Statistics

Publications

11

Citations

852

H-Index

10

Active since

2004

Affiliations

University Hospitals Cleveland Medical Center(Current)

MetroHealth Medical Center

Hospital Británico de Buenos Aires

Therapeutics Clinical Research

The George Institute for Global Health

Aparna Padiyar is an author at University Hospitals Cleveland Medical Center specializing in medicine, nephrology, and chronic kidney disease.

Top concepts

Publications per year

2004–2023

11

Publications

11

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

, , +9

Independent of Nephrectomy, Weaning Immunosuppression Leads to Late Sensitization After Kidney Transplant Failure

Joshua J. Augustine, Kenneth J. Woodside, Aparna Padiyar et al. · Transplantation · 2012 · 98 citations

A WT1 Co-regulator Controls Podocyte Phenotype by Shuttling between Adhesion Structures and Nucleus

Manakan B. Srichai, Martha Konieczkowski, Aparna Padiyar et al. · Journal of Biological Chemistry · 2004 · 89 citations · Full text

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Rows per page

1–5 of 11